首页> 外国专利> HEPATITIS E VIRUS ORF2 CAPSID POLYPEPTIDES AND USES THEREOF

HEPATITIS E VIRUS ORF2 CAPSID POLYPEPTIDES AND USES THEREOF

机译:肝炎病毒ORF2衣壳多肽及其用途

摘要

Hepatitis E virus (HEV) is responsible for over 50% of acute viral hepatitis cases worldwide. The inventors have now identified the precise sequence of infectious particle-associated ORF2 capsid protein. Strikingly, their analyses revealed that in infected patients, HEV produces three forms of the ORF2 capsid protein: ORF2i, ORF2g and ORF2c. The ORF2i protein is associated with infectious particles whereas ORF2g and ORF2c proteins are massively produced glycoproteins that are not associated with infectious particles and are the major antigens present in HEV-infected patient sera. Accordingly, the ORF2i and ORF2g proteins are thus the subject matter of the present invention as well as antibodies specific for the proteins and diagnostic assays (e.g. ELISA) for the diagnosis of Hepatitis E virus infection.
机译:戊型肝炎病毒(HEV)占全球急性病毒性肝炎病例的50%以上。发明人现在已经确定了感染性颗粒相关的ORF2衣壳蛋白的精确序列。令人惊讶的是,他们的分析表明,在感染的患者中,戊型肝炎病毒产生三种形式的ORF2衣壳蛋白:ORF2i,ORF2g和ORF2c。 ORF2i蛋白与感染性颗粒相关,而ORF2g和ORF2c蛋白是大量产生的糖蛋白,与感染性颗粒无关,并且是HEV感染患者血清中的主要抗原。因此,ORF2i和ORF2g蛋白以及该蛋白特异的抗体和用于诊断戊型肝炎病毒感染的诊断测定法(例如ELISA)是本发明的主题。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号